Navigation Links
MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013
Date:5/23/2013

SAINT PAUL, Minn., May 23, 2013 /PRNewswire/ -- MGC Diagnostics Corporation (NASDAQ: MGCD) (formerly Angeion Corporation), a global medical technology company, today scheduled a conference call to discuss its financial results for the second quarter of fiscal year 2013, ended April 30, 2013. The call will be at 4:30 p.m. ET on Thursday, May 30, 2013. The Company will report financial results for the second quarter of fiscal year 2013 after the markets close on Thursday, May 30, 2013.

(Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO)

Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or listen via a live Internet webcast on the Company's website at www.mgcdiagnostics.com. A replay of the conference call will be available by dialing (877) 344-7529 or (412) 317-0088, confirmation code 10029021, through June 6, 2013. A webcast replay of the conference call will be accessible on the Company's website at www.mgcdiagnostics.com for 90 days.

About MGC Diagnostics
MGC Diagnostics Corporation (NASDAQ: MGCD), (formerly Angeion Corporation), is a global medical technology company dedicated to cardiorespiratory health solutions. MGC Diagnostics develops, manufactures and markets non-invasive diagnostic systems. This portfolio of products provide solutions for disease detection, integrated care, and wellness across the spectrum of cardiorespiratory healthcare. The Company's products are sold internationally through distributors and in the United States through a direct sales force targeting heart and lung specialists located in hospitals, university-based medical centers, medical clinics, physicians' offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations (CROs). For more information about MGC Diagnostics, visit www.mgcdiagnostics.com. Contact:

Wesley W. Winnekins

Joe Dorame, Robert Blum, Joe DiazMGC Diagnostics Corporation

Lytham Partners, LLCChief Financial Officer

(602) 889-9700(651) 484-4874

mgcd@lythampartners.com 

 


'/>"/>
SOURCE MGC Diagnostics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. QBC Diagnostics Awarded GSA Contract
2. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
3. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
4. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
5. ZINO Society Targets Medical Devices, Healthcare IT and Diagnostics
6. Quest Diagnostics To Speak At The Wells Fargo Securities 2012 Healthcare Conference
7. Breakthrough Prostate Cancer Diagnostics
8. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
11. Quest Diagnostics to Release Second Quarter 2012 Financial Results on July 19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2020)... ... January 09, 2020 , ... R3 Stem Cell, the ... freezer program. The cryogenic freezer allows practices to have plenty of stem cell ... exosome biologics require cryogenic freezing. This may include a practice receiving the biologics ...
(Date:1/7/2020)... ... January 07, 2020 , ... Ironsphere, ... service providers, announced today it has been selected by MetLife Stadium for Privileged ... , “As part of our ongoing commitment to maintain the highest of security ...
(Date:1/7/2020)... TORONTO (PRWEB) , ... January 06, 2020 , ... Myant ... that enable continuous and ambient heart health management at CES 2020 (January 7-10, Las ... as a winner in the Health & Wellness category of the CES 2020 Innovation ...
Breaking Medicine Technology:
(Date:1/23/2020)... ... January 23, 2020 , ... DelawareBio, a nonprofit trade ... a panel discussion on gene editing that goes beyond CRISPR technology. To be ... Education Center, the event will provide an overview of the opportunities and challenges ...
(Date:1/23/2020)... ... January 23, 2020 , ... Three leading healthcare organizations, ... to improve diagnostic quality and safety by joining the Coalition to Improve ... healthcare and patient advocacy. , “Diagnostic error is one of the most important ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... and risk services for organizations that operate vehicle fleets in North America and ... subscriber-based e-newsletter, will be published monthly with content accessible on the company’s website. ...
(Date:1/23/2020)... Texas (PRWEB) , ... January 23, 2020 , ... ... announced a strategic partnership using SocialClimb’s innovative technology to power the Arrowlytics platform ... practice efficiency and profitability. SocialClimb’s platform integrates seamlessly with practice management systems to ...
(Date:1/22/2020)... (PRWEB) , ... January 22, ... ... cloud-based ambulatory EHR , revenue cycle management services, integrated practice management, ... System, Hospital Information Management System and Personal Health Record for Indian healthcare ...
Breaking Medicine News(10 mins):